ASD vs IXJ

Side by side

	ASD	IXJ
Fund	Defiance Autism Impact ETF	iShares Global Healthcare ETF
Issuer	Defiance	iShares
Category	ESG & Values	Health Care
Expense ratio	0.79%	0.38%
Assets	$1.4M	$4.5B
Average daily dollar volume	$25K	$17M
Listed	Jun 1, 2026	Nov 13, 2001
FrenzyCap score	16	67
1-month return	−0.3%	+5.1%
3-month return	−0.9%	+8.1%
Year to date	—	+10.1%
1-year return	—	+17.9%
30-day volatility	13.0%	16.9%
Worst drawdown, 1 year	−7.7%	−10.8%
Trailing 12-month yield	0.03%	1.35%
Holdings	39	129
Top 10 weight	30.8%	47.4%
Look-through P/E	—	36.7
Holdings vs fair value	+20.0%	+2.1%
Holdings above 200-day average	55%	87%
Net flow, latest 3 reported months	+$1.3M thru Jun 2026	+$41M thru Jun 2026
30-day implied volatility	—	20.0%
Holdings as of	as of Jun 30, 2026SEC filing	as of Oct 14, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

30% of ASD · 36% of IXJ

Holding	ASD	IXJ
ABBV	2.72%	5.52%
JNJ	2.59%	6.74%
Novartis AG	2.53%	3.24%
Roche Holding AG	2.50%	3.76%
LLY	2.49%	10.65%
PFE	2.25%	2.02%
BMY	2.47%	1.47%
GSK	2.46%	1.17%
Takeda Pharmaceutical Co Ltd	2.35%	0.72%
Otsuka Holdings Co Ltd	2.95%	0.40%
RVTY	2.69%	0.21%
Shionogi & Co Ltd	2.29%	0.17%

Sector mix of the stock holdings

Sector	ASD	IXJ	Gap
Health Care	46.8%	70.5%	−23.7%
Technology	2.7%	7.5%	−4.8%
Consumer Discretionary	6.8%	0.0%	+6.8%
Other	2.7%	0.0%	+2.7%
Consumer Staples	0.0%	1.9%	−1.9%
Industrials	0.0%	0.1%	−0.1%

More: full overlap table · ASD holdings · IXJ holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.